SUBSCRIBE

CATEGORIES

Brazil top court gives nod for probe into Bolsonaro over vaccine deal

imageStock Markets35 minutes ago (Jul 03, 2021 11:15AM ET)

(C) Reuters. FILE PHOTO: Brazil’s President Jair Bolsonaro gets in a vehicle after attending Mass at a Catholic church in Brasilia, Brazil July 1, 2021. REUTERS/Adriano Machado

SAO PAULO (Reuters) – Brazil’s Supreme Court Justice Rosa Weber late on Friday authorized an investigation of President Jair Bolsonaro by the top prosecutor’s office, or PGR, for dereliction of duty in the process of procuring an Indian COVID-19 vaccine, according to a copy of the decision seen by Reuters.

The president has been implicated in allegations of irregularities surrounding a 1.6 billion reais ($316 million) contract signed in February for 20 million doses with a Brazilian intermediary for the vaccine’s maker, Bharat Biotech.

A Brazilian Senate commission investigating the administration’s handling of the pandemic has cited suspicions of overpricing and corruption related to the contract. After allegations of irregularities surfaced, the government suspended the contract.

Brazil has suffered the world’s second highest number of COVID-19 deaths.

Brazilian federal prosecutors and the comptroller general’s office, or CGU, are also separately investigating the alleged irregularities in the deal. The case allegedly involves the government’s chief whip in the lower house of Congress, Ricardo Barros, according to lawmakers.

Bolsonaro and Barros denied any wrongdoing.

The investigation of the president by the PGR had to be formally authorized by the Supreme Court. In her decision, Justice Weber gave authorities 90 days for collection of evidence pertaining to the case.

Brazil top court gives nod for probe into Bolsonaro over vaccine deal

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.